Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)

被引：4
|
作者：
Smalley, Walter [1 ,2 ]
Falck-Ytter, Corinna [3 ,4 ]
Carrasco-Labra, Alonso [5 ]
Wani, Sachin [6 ]
Lytvyn, Lyubov [5 ]
Falck-Ytter, Yngve [3 ,4 ]
机构：
[1] Vanderbilt Univ, Sch Med Med Gastroenterol, Nashville, TN 37212 USA
[2] VA Tennessee Valley Hlth Care Syst, Nashville, TN 37212 USA
[3] Case Western Reserve Univ, Med Gastroenterol, Cleveland, OH 44106 USA
[4] VA Northeast Ohio Hlth Syst, Cleveland, OH USA
[5] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[6] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
来源：
GASTROENTEROLOGY | 2019年 / 157卷 / 03期
关键词：
D O I：
10.1053/j.gastro.2019.07.053
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：858 / 858
页数：1
相关论文
共 50 条
  • [1] AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 851 - 854
  • [2] AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Carrasco-Labra, Alonso
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    Surawicz, Christina M.
    Chey, William D.
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 859 - 880
  • [3] AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D): Patient Summary
    American Gastroenterological Association
    [J]. GASTROENTEROLOGY, 2019, 157 (03) : 856 - 857
  • [4] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [5] Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction
    Habba, Saad F.
    [J]. MEDICAL HYPOTHESES, 2011, 76 (01) : 97 - 99
  • [6] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [7] Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu, Xiao-juan
    Liu, Liang
    Yao, Shu-kun
    [J]. JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2016, 17 (01): : 1 - 9
  • [8] Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
    Breslin, Henry J.
    Diamond, Craig J.
    Kavash, Robert W.
    Cai, Chaozhong
    Dyatkin, Alexey B.
    Miskowski, Tamara A.
    Zhang, Sui-Po
    Wade, Paul R.
    Hornby, Pamela J.
    He, Wei
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4869 - 4872
  • [9] Stool microbiota characterization in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) receiving repeat Rifaximin
    Pimentel, M.
    Fodor, A. A.
    Golden, P. L.
    Bortey, E.
    Forbes, W. P.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 100 - 100
  • [10] The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
    Ding, Xiaojie
    Sun, Xiling
    Yu, Xiaofei
    Zhao, Shutian
    Yang, Yi
    Xu, Wenjuan
    Wang, Kejun
    Zou, Xiaolan
    Dong, Zhengping
    [J]. 2018 INTERNATIONAL CONFERENCE ON BIOTECHNOLOGY AND BIOENGINEERING (8TH ICBB), 2019, 2079
12345